TNON stock forecast scenarios highlight upside risk if Q3 product launches achieve higher-than-expected market share, a variable analysts are closely modeling. SNL returns swinging as Trump sketch rips into wars, late ... Tenon Medical has a consensus price target of $5.50, representing about 347.2% upside from its current price of $1.23. TNON stock forecast reflects a favorable long-term outlook due to increased R&D spending, tied to future product pipelines. This positions it competitively within its tech vertical, supporting sustained equity appreciation.